Navigation Links
Memory Clinics are Diverting NHS Resources from High Quality Care

Specialist memory clinics for patients with dementia are taking NHS resources away from long term integrated care, warn senior doctors in this week’s BMJ.//

Since 2001, the National Institute for Health and Clinical Excellence (NICE) has recommended that cholinesterase inhibitors should be available to people with mild to moderate Alzheimer’s disease, writes consultant psychiatrist, Anthony Pelosi and colleagues.

This was based on evidence that these drugs slowed cognitive (mental) decline, but NICE stressed that further research was required and it planned to revisit its recommendations after several years.

The guidelines were welcomed by patient and carer organisations, and a large number of specialist memory clinics were set up for the prescription and monitoring of these medicines, sometimes with funding from the drug manufacturers.

But widespread clinics have distorted clinical priorities, argue the authors. They have recruited full multidisciplinary teams while there is a shortage of mental health professionals throughout the United Kingdom, and they do not offer care in the community to their patients as they decline. Patients then have to be referred to ordinary old age psychiatry teams, which have to arrange proper long-term management plans.

Further research is now available and shows quite consistently that these medicines have modest beneficial effects compared with placebo. As a result, NICE recommended that the NHS should no longer prescribe cholinesterase inhibitors because they do not provide value for money.

But after hostile reactions from clinicians, patients and carers, with support from the lay media, NICE now proposes restricting use to moderate Alzheimer’s disease. But doctors are concerned that it will be extremely difficult (perhaps impossible) to wait for a diagnosed patient to deteriorate before starting treatment.

NICE has been unfairly accused of ageism a nd stigmatisation of people with dementia, and it has been claimed that adoption of the revised guidelines would be devastating for patients and carers. But the tragedy is not the proposed restrictions, but the fact that the only currently licensed medicines for a cruel illness have turned out to be of marginal benefit, write the authors.

Whatever the final outcome of NICE’s deliberations, the human and financial resources that have become tied up in clinics organised around prescription of cholinesterase inhibitors must be diverted to old age psychiatry teams and their social care counterparts, they say.

These medicines should no longer be allowed to have such influence on services for patients with Alzheimer’s disease and their families.



Source-Newswise'"/>




Related medicine news :

1. Memory problem? solve a crossword
2. Deep Sleep Doesnt Increase Memory
3. For a Better Memory
4. Memory loss associated with microbes
5. Memory loss always goes hand with Depression
6. Memory deprivation after operations
7. Sage Improves Memory
8. Memory said to automatically improve with age
9. Enzyme Associated with Memory
10. Enzyme Associated With Memory
11. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... , ... May 25, 2016 , ... ... International University (FIU) Herbert Wertheim College of Medicine announced the AUA-FIU Global MD ... Degree and Global Health Certificate from AUA and a Certificate of Completion from ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Today Omega ... launch of 11 innovative workshops and training opportunities in the growing field ... unique needs of individuals who are dealing with specific health issues—including injuries, illnesses, and ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit ... unique integrative medical wellness offerings of Europe, a continent that pioneered the medical/wellness concept ... hear from numerous pioneers in medical wellness, including Henri Chenot, Founder of the Chenot ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... the results of its annual Medical and Prescription Drug survey , an ... , The survey, which was conducted in December 2015, indicates that employers ...
(Date:5/25/2016)... ... 25, 2016 , ... Laser Skin & Wellness Center is excited ... time of female aging. The Juliet™ procedure helps to reverse the ... leakage, laxity, itchiness and pain have reported real relief from these and other problems ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... WASHINGTON , May 23, 2016 The World ... PrePex device to include adolescents aged 13 years, ... MedTech, can be offered for adult and adolescent males in ... Africa . PrePex was the first male circumcision device ... Circ MedTech,s CEO, Eddy Horowitz said: " The ...
(Date:5/23/2016)... Gamida Cell, a leader in ... and orphan genetic diseases, announced today it has been ... the Israel Innovation Authority (formerly the Office of the ... Industry. The mission of the Israel Innovation Authority is ... science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... DUBLIN , May 23, 2016 ... to develop its anti-fibrotic and anti-inflammatory compound DS102 ... well as in non-alcoholic steatohepatitis (NASH) patients. ... is significantly sequestered in lung tissue and has ... tissue after oral administration. The Company will publish ...
Breaking Medicine Technology: